Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Omadacycline tosylate by Paratek Pharmaceuticals for Mycobacterium Infections: Likelihood of Approval
Omadacycline tosylate is under clinical development by Paratek Pharmaceuticals and currently in Phase II for Mycobacterium Infections. According to GlobalData,...
Data Insights
Omadacycline tosylate by Paratek Pharmaceuticals for Osteomyelitis: Likelihood of Approval
Omadacycline tosylate is under clinical development by Paratek Pharmaceuticals and currently in Phase I for Osteomyelitis. According to GlobalData, Phase...